Affinity Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$353K Sell
964
-53
-5% -$18.1K 0.04% 131
2026
Q1
$358K Sell
1,017
-16
-2% -$5.7K 0.05% 121
2025
Q4
$338K Buy
1,033
+179
+21% +$56.8K 0.05% 123
2025
Q3
$254K Buy
854
+25
+3% +$7.25K 0.04% 131
2025
Q2
$231K Sell
829
-32
-4% -$9.06K 0.04% 143
2025
Q1
$246K Buy
861
+37
+4% +$10.9K 0.05% 134
2024
Q4
$216K Hold
824
0.04% 145
2024
Q3
$265K Sell
824
-6
-0.7% -$1.96K 0.05% 131
2024
Q2
$259K Hold
830
0.05% 130
2024
Q1
$236K Buy
830
+17
+2% +$4.97K 0.05% 136
2023
Q4
$234K Buy
813
+67
+9% +$18.3K 0.06% 127
2023
Q3
$201K Buy
+746
New +$186K 0.06% 130
2023
Q1
Sell
-826
Closed -$217K 125
2022
Q4
$217K Buy
+826
New +$221K 0.07% 100
2022
Q3
Sell
-826
Closed -$201K 110
2022
Q2
$201K Buy
+826
New +$202K 0.07% 105
2021
Q1
Sell
-874
Closed -$201K 122
2020
Q4
$201K Buy
874
+5
+0.6% +$1.15K 0.08% 113
2020
Q3
$221K Hold
869
0.13% 99
2020
Q2
$205K Hold
869
0.13% 94
2020
Q1
$204K Sell
869
-73
-8% -$15.9K 0.15% 93
2019
Q4
$227K Buy
+942
New +$208K 0.15% 103

Other funds holding AMGN

Affinity Capital Advisors's AMGN Position: Q2 2026 in Review

Affinity Capital Advisors reduced its Amgen (AMGN) stake by 5.2% in Q2 2026, selling an estimated $18.1K and leaving 964 shares worth $353K. The position accounts for 0.04% of the portfolio, ranked #131.

Affinity Capital Advisors first reported a position in AMGN in Q4 2019 and has held it in 19 quarters since. The position peaked at $358K in Q1 2026. 575 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Affinity Capital Advisors held 964 shares of Amgen worth $353K as of Q2 2026.
  • Affinity Capital Advisors sold 53 Amgen shares in Q2 2026, an estimated $18.1K.
  • Amgen made up 0.04% of Affinity Capital Advisors's portfolio in Q2 2026, its #131 holding.
  • Affinity Capital Advisors first reported a position in Amgen in Q4 2019 and has held it in 19 quarters since.
  • Affinity Capital Advisors's Amgen position peaked at $358K in Q1 2026.
  • 575 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Affinity Capital Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.